Related Experiment Videos
Characterization of chromosome 17 abnormalities in medulloblastomas
N Aldosari1, B K Rasheed, R E McLendon
1Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA.
Acta Neuropathologica
|April 29, 2000
Summary
Chromosome 17p deletions in medulloblastoma occur via multiple mechanisms, including isochromosome formation, terminal deletions, translocations, and recombination. Understanding these diverse genetic alterations is key to medulloblastoma research.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Medulloblastomas frequently exhibit alterations of chromosome 17p.
- Loss of heterozygosity (LOH) studies sometimes indicate terminal deletions, contrasting with typical isochromosome 17q formation.
Purpose of the Study:
- To investigate the spectrum of chromosome 17 abnormalities in medulloblastoma.
- To reconcile cytogenetic and LOH findings in medulloblastoma cell lines and xenografts.
Main Methods:
- Routine karyotyping
- Fluorescence in situ hybridization (FISH)
- Loss of heterozygosity (LOH) studies
- Chromosome 17 painting
Main Results:
- Identified diverse chromosome 17 abnormalities including i(17q), terminal deletions, unbalanced translocations, and homologous recombination.
- Demonstrated that apparent i(17q) can arise from unbalanced translocations.
- Showed terminal deletions potentially originating from i(17q) breakage.
Conclusions:
- Chromosome 17p deletions in medulloblastoma arise through various mechanisms.
- These mechanisms include i(17q), terminal deletions, unbalanced translocations, and homologous recombination.